Form D · Other Health Care
Teal Bio, Inc.
Somerville, MA · CIK 0001844442
Offering snapshot reported Dec 27, 2023 · SEC filing
- Reported sold
- $219K Offering amount: $950K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 16, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 27, 2023 | Initial | $218,634 | No comparison | 4 | SEC filing |
| Feb 6, 2023 | Amendment | $3,000,000 | $500,000vs Nov 23, 2021 | 15 | SEC filing |
| Nov 23, 2021 | Initial | $2,500,000 | No comparison | 14 | SEC filing |
| Feb 5, 2021 | Initial | $575,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-500840
Source: Form D, filed Dec 27, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tony Casciano | Director, Executive |
| Sophie Kornowski | Director |
| Robert Langer | Director |
| Michael Singer | Executive |
| Carlo Traverso | Director |
| Jason Troutner | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
444 Somerville Avenue
Somerville, MA, 02143
Somerville, MA, 02143